Page last updated: 2024-11-04

sulfamethoxazole and Adenoma, Prostatic

sulfamethoxazole has been researched along with Adenoma, Prostatic in 3 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lopes, DL1
Araújo, Sde A1
Santos, JP1
Lyon, AC1
Dantas, DV1
Reis, BS1
de Góes, AM1
Pedroso, ER1
Sakuragi, T1
Nielsen, ML1
Laursen, H1
Christensen, P1

Other Studies

3 other studies available for sulfamethoxazole and Adenoma, Prostatic

ArticleYear
Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer.
    Memorias do Instituto Oswaldo Cruz, 2009, Volume: 104, Issue:1

    Topics: Antiprotozoal Agents; Diagnosis, Differential; Humans; Itraconazole; Male; Middle Aged; Paracoccidio

2009
[Study on levels of chemotherapeutics in prostatic tissue and prostatic fluid or seminal plasma. 2. Concentrations of erythromycin (EM), aminobenzylpenicillin (ABPC)-methylchlorophenylisoxazolylpenicillin (MCIPC) and sulfamethoxazole-trimethoprim (SMX-TMP
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1979, Volume: 70, Issue:4

    Topics: Ampicillin; Animals; Body Fluids; Dogs; Drug Combinations; Erythromycin; Male; Oxacillin; Prostate;

1979
Control of bacteriuria with sulphamethoxazole-trimethoprim in patients with urinary tract obstruction and chronic infection. A preliminary report.
    Scandinavian journal of urology and nephrology, 1972, Volume: 6, Issue:3

    Topics: Adult; Aged; Anti-Infective Agents; Bacteriuria; Female; Folic Acid Antagonists; Humans; Male; Middl

1972